BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Endothelial cell
,
Alcohol
,
Doxorubicin
,
rs2476601
,
PRKCA
,
calcium channel activity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
florbetapir
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Development of software for measuring brain amyloid accumulation using 18 F-florbetapir PET and calc…
Decreased imaging time of amyloid PET using [18F]florbetapir can maintain quantitative accuracy.
Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical tria…
18F-florbetapir PET as a marker of myelin integrity across the Alzheimer's disease spectrum.
18F-Florbetapir PET in Primary Cerebral Amyloidoma.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Florbetapir Calibration to the Centiloid Scale
The Role of F-18 Florbetapir in the Early Detection of Cardiac Amyloidosis
The Feasibility of Florbetapir Quantitation
Cardiac Uptake of 18F Florbetapir in Patients Undergoing Chemotherapy
Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ